FBIO - Journey Medical Corporation to Participate in the 36th Annual ROTH Conference | Benzinga
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical") (NASDAQ:DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California.
Claude Maraoui, President and Chief Executive Officer, will participate in a fireside chat on Monday, March 18 at 9:30 a.m. PT and will be available for one-on-one ...